-
Sobli
—
1/8
The headquarters of Roche Diagnostics in Rotkreuz ZG. Among other things here …
—-
zVg
—
2/8
… we are working intensively on the development of new methods for the detection of the corona virus.
—-
Zvg
—
3/8
Roche plans to launch an antibody test in May that can also be processed quickly on its own test machines.
—-
keystone
—
7/8
First study suggests that remdesivir can reduce fever and fight inflammation of the lungs in corona patients.
—-
keystone
—
8/8
Another advantage of Remdesivir: The drug is already being produced and does not have to be redeveloped.
—-
—-
This gives hope: The pharmaceutical companies around the world are working intensively and in special shifts on funds in the fight against the corona virus. At the forefront: the Swiss pharmaceutical industry. The pharmaceutical company Roche, for example, is developing a new test for the detection of corona antibodies and plans to launch it in May.
–
This test should now help to detect the corresponding antibodies in those who had the coronavirus, Roche said. The aim is to have the antibody test available by the beginning of May in countries that accept the CE marking of the European Union. At the same time, Roche is working with the US drug agency FDA for an emergency approval.
–
Important step towards normality
Antibody tests play a key role in identifying exactly those people who may have been infected with the virus but have shown no symptoms, as the release says.
–
In addition, a test is said to support priority screening of high-risk groups. This includes, for example, healthcare or food supply workers who may have already developed some level of immunity and can continue to work or return to work.
–
The antibody test is an important next step in the fight against the corona pandemic. The Roche antibody test can be quickly produced in large numbers.
–
Ebola medication helps with severe symptoms
A drug from the US pharmaceutical company Gilead Science shows, according to a media report, success in the treatment of patients suffering from the coronavirus. In a study by the University Clinic in Chicago, Remdesivir, which was originally developed against Ebola, led to a rapid reduction in fever and a reduction in the symptoms of the lung disease.
–
As a result, almost all of the patients were discharged in less than a week, according to a report released on Thursday by the online medical news platform, Stat. The company’s shares rose 16 percent after the US market closed.
–
Gilead dampens expectations
Gilead said the data still had to be analyzed to draw conclusions. The university clinic indicated in an email that partial data from an ongoing study should not be used to derive results. Information from an internal forum for scientists was published without permission.
–
The pharmaceutical company expects to be able to announce the first results from the ongoing phase 3 study at the end of the month. The University Clinic in Chicago is one of 152 hospitals participating in the Gilead study in seriously ill patients. According to the Stat news platform, 113 people were treated in Chicago as part of the study. (SDA / koh)
–
Corona virus—
The corona virus currently occupies the whole world and there are new developments every day. All current information and figures on the subject are available in the Coronavirus ticker.
——
Related
